Amid the nationwide action against Nestle India over its instant noodle brand Maggi, Uttar Pradesh Food Safety and Drug Administration (FDA) is still not considering a ban on the product even as several states have already done so.
A batch of Maggi collected by the Barabanki district unit of FDA from Easy Day retail outlet during a routine checking in March 2014 was found to be containing lead and monosodium glutamate (MSG) above the permissible limit in lab tests.
Later, the FDA had directed Nestle India to recall the batch, which was complied with by the company.
FDA has already filed a court case against six persons/companies, including Nestle and Easy Day, in a Barabanki local court, which posted the next hearing on July 1.
Another case was also filed by a local lawyer against top Bollywood actors including Amitabh Bachchan, Madhuri Dikshit and Priety Zinta for endorsing Maggi as a safe and nutritious food. This case would be heard on June 19.
"As of now, we are not contemplating to ban Maggi in UP as we have already taken action in the matter and ordered for the recall of the batch," UP FDA Commissioner P K Singh told Business Standard.
Meanwhile, the various district units of FDA in the state have been collecting samples of Maggi for further checking to ensure they are safe for consumption.
"As a precaution, we are collecting the subsequent batches of Maggi for lab testing and it has been kept under our constant surveillance," he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app